Join Dr. Robert Gould and Michael Girand as they discuss methods and applications for the use of EEG as a biomarker for sleep, substance use disorder and CNS disorders.
Electroencephalography (EEG) represents one of the primary methods to measure brain function in a non-invasive manner in humans and animals, thus providing a highly translational and powerful research tool to enhance basic academic as well as drug discovery research programs.
In this webinar sponsored by Data Sciences International (DSI), Dr. Robert Gould, Assistant Professor of Physiology and Pharmacology at Wake Forest School of Medicine, highlights several methods and applications for using EEG in freely moving rodents to enhance or complement research on CNS disorders. One well-known application of quantitative EEG (qEEG) is to examine different oscillatory patterns of brain function (e.g. diurnal rhythm, disease progression, pharmacological manipulations, etc.). In addition, Dr. Gould discusses how EEG can be used to study sleep architecture and arousal, addiction/substance use disorder, schizophrenia and drug discovery.
Michael Girand, Scientific Applications Manager at DSI, conveys a holistic approach when studying CNS-based applications and discusses how researchers can improve their study design and get more endpoints out of the animal model.
To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.
Assistant Professor, Physiology and Pharmacology
Wake Forest School of Medicine
Scientific Applications Manager
Data Sciences International